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Many molecular and cellular mechanisms that drive the physiological functions of cells or control
the development of an animal are well conserved between vertebrates and insects. This conservation
makes the genetically and experimentally tractable Drosophila a valuable model to study human
development and diseases. The high similarity of these processes is illustrated by the fact that
close to two out of three human disease genes have Drosophila counterparts that are thought to be
functional homologs.
The availability of extensive resources and sophisticated genetic tools allows researchers to
efficiently generate Drosophila disease models for numerous disorders with the goal of identifying the
etiology of these human diseases. Knowledge about a disease pathway often points to novel possible
therapeutic targets, and whole organism screening for compounds that interact with the pathway.
Because Drosophila allows researchers to adjust the genetic background, whole organism Drosophila
disease models will also play an important role in the future of personalized medicine.
Major granting agencies all over the world have recognized the tremendous value of model
organisms, including Drosophila, for the study of human diseases. Accordingly, they have started
programs to foster the interaction between researchers studying human patients and researchers
studying neurobiological, developmental and physiological processes in vertebrate and non-vertebrate
model systems. Oriel and Lasko [1] provide an overview of these programs, highlighting the role that
Drosophila plays in understanding human diseases and how the fly is used for exploiting potential
therapeutic targets. In addition to granting agencies, human disease research using Drosophila is also
facilitated by databases and websites that link the relevant information and display them for interested
researchers. Flybase (http://flybase.org) compiles the human disease model data for Drosophila, and
efforts from around the world continuously produce additional supporting information. In this issue,
Wei et al. [2] present their database that links human miRNAs and their disease-related target genes
with predicted Drosophila counterparts.
Several reviews cover the present knowledge on Drosophila research designed to reveal pathogenic
mechanisms and to explore possible therapeutic strategies. Souidi et al. [3] have reviewed the field of
Myotonic Dystrophy Type 1. Dietary effects and consequences of obesity have been studied extensively
in flies and different aspects of these studies are covered in this issue as well. Lian et al. [4] reviewed
such effects on gut metabolic homeostasis, immune function and aging. Gáliková and Klepsatel [5]
discuss the effects of obesity on life span, physiology and aging, and Warr et al. [6] explore links
between dietary conditions, obesity, diabetes and cancer. Drosophila is being used heavily for cancer
related research and Trivedi and Starz-Gaiano [7] have focused their review on the Jak/Stat signaling
pathway and its role in cell differentiation, migration, proliferation and cancer, and on the value of
screening for drugs using Drosophila. The article by Powers and Srivastava [8] discusses the value of
two fly models for cell migration and metastasis. One model was introduced some time ago and the
other is a novel one.
Because of its relative simplicity and the elaborated genetic tools available, the fly nervous
system, including the brain, has been another main focus of Drosophila research relating to human
disease. Lye and Chtarbanova [9] present a review on innate immunity and inflammatory reactions
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with a focus on its value and dangers for the brain. Kasture et al. [10] reviewed the knowledge
about dopaminergic and serotonergic neurotransmission in the fly brain. They point out how this
knowledge helps in understanding human health-related neuronal functions and disease mechanisms,
and also in finding potential ways to treat such diseases. Many other contributors have focused
their reviews on various aspects of neurodegeneration. Nagoshi [11] reviewed the contribution of
Drosophila to identifying risk factors and providing mechanistic insights into the pathogenesis of
sporadic Parkinson’s disease. She also discusses the potential of Drosophila for the development of
preclinical animal models. Rosas-Arellano et al. [12] reviewed the work on Huntington’s disease and
what improves this disease phenotype, and Monnier et al. [13] discuss how Drosophila research helped
understanding of the development and progression of Friedreich’s ataxia and how these results led to
the development of ideas of what drugs could ameliorate the condition. Vandal et al. [14] present the
knowledge gained about Frontotemporal dementia with a special focus on a truncation mutation in
the CHMP2B locus that affects the endosomal–lysosomal pathway and causes neurodegeneration.
This special issue also contains two research papers in which Drosophila researchers address
human health issues in the fruit fly. Using the Drosophila eye, Poon et al. [15] investigated how Src
and oncogenic ras cooperate in epithelial tumor formation. The second research article relates to
neurodegeneration. In different neurodegenerative diseases in humans, the nuclear RNA binding
protein TDP-43 (TBPH in flies) is found in unusual cytoplasmic hnRNP structures that have been
linked to ALS and FTD. Lo Piccolo et al. [16] now show that very similar structures also appear in the
cytoplasm of Drosophila tissue if the ISWI chromatin modifier is mutated. They used the Drosophila
system to study the formation of these cytoplasmic inclusions to obtain insights into the etiology of
neurodegeneration associated with cytoplasmic TDP-43/TBPH inclusions.
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